Media & Press Updates
What’s Happening
News
​​​
-
New -April 21, 2021 - National Cancer Institute (NCI) technologies added to OniX
​​
-
Coming soon - TBA - Partnering, In/Out Licensing and Funding opportunities in:​
-
Osteoarthritis
-
Neurosciences: Alzheimer's, Mild Cognitive Impairment, Parkinson's, Depressive Disorders, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Multiple System Atrophy (MSA), Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, Huntington's and others
-
Orthopedic/Musculoskeletal Diseases, Metabolic Diseases and CNS Diseases
-
Skin Diseases
-
Oncology: Lung, Pancreas, Breast, Skin, Prostate, Blood, and others
-
Gastrointestinal, Liver and Pancreatic Diseases
-
Rare Neurological Disorders
-
Lysosomal Storage Disorders
-
Others: Agriculture, Animal Health, Energy, Food & Nutrition and others
-
​​
-
September 1, 2020: OniX and Skipper Bio Med Partner to advance Lung and Pancreatic Cancer research
-
October 29, 2019: THE OniX - ALTUM Competitive Advantage: Transform the grants, prizes and challenges experience
-
October 22, 2019: OniX partners with Altum to accelerate research:Grants|Prizes|Challenges Initiative
-
October 14, 2019: OniX: New Startup Changing The Game

OniX Virtual Travels
-
Sept 21-22: 2020 BIO IMPACT: Ag & Environment Conference
-
Sept 21-24: BIOPHARM AMERICA
-
Oct 26-29: BIO-EUROPE
-
Dec 1-4: RARE DISEASE INNOVATION AND PARTNERING SUMMIT